Skip to main content
Inicio
language-selector-globe Mexico | es
Selecciona localización
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Mexico
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Novartis México 
      • Novartis en México 
      • Nuestra Estrategia 
      • Cultura y Asociados 
      • Equipo Directivo 
      • Contáctanos 
      Profesionales en laboratorio Novartis México
    • Nuestro Compromiso con México 
      • Impacto en México 
      • Financiamiento Externo 
      • Ética, Riesgo y Cumplimiento 
      • Acceso 
      • Sostenibilidad Ambiental 
      • Salud Global 
      Paciente y profesional de la salud tomándose las manos Nuestro Compromiso con México
    • Sala de Prensa 
      • Contacto para Prensa 
      Profesional trabajando en laboratorio Sala de Prensa
    • Somos el Lugar para Crecer 
      • Oportunidades Laborales 
      • Nuestra Propuesta de Valor 
      • Nuestra Forma de Trabajo 
      • Bienestar 
      • Diversidad e Inclusión (D&I) 
      • Programas de Atracción de Talento 
      • Rankings y Certificaciones 
      Personas hablando en una sala de juntas Somos el Lugar para Crecer
    Imagen panorámica de campo de agave en México Inicio
  1. Inicio
  2. Somos el Lugar para Crecer
  3. Oportunidades Laborales
  • Sort by Sort ascending
  • Título profesional
  • Sitio
  • Ubicación
  • División Sort ascending
  • Negocio
  • Functional Area
  • Fecha de publicación
Título profesional Sitio Ubicación División Sort ascending Negocio Functional Area Fecha de publicación
Record to Report Sr. Specialist USA INSURGENTES México Finance CTS Auditoría y Finanzas Oct 23, 2024
Record to Report (R2R) Specialist New Cairo Egipto Finance CTS Auditoría y Finanzas Oct 18, 2024
Record to Report (R2R) Section Head New Cairo Egipto Finance CTS Auditoría y Finanzas Oct 18, 2024
LDC Solution Design Manager RDF Prague República Checa Finance CTS Auditoría y Finanzas Oct 21, 2024
Finančni analitik poslovnega planiranja in analiz (m/ž/d) / BPA Finance Analyst (m/f/d) Ljubljana Eslovenia Finance Innovative Medicines Auditoría y Finanzas Oct 21, 2024
BPA Manager - Global Process Owner Hyderabad (Office) India Finance Corporate Auditoría y Finanzas Oct 24, 2024
CTS Business Planning Analysis Manager INSURGENTES México Finance CTS Auditoría y Finanzas Oct 24, 2024
Senior Source to Pay Business Partner Prague República Checa Finance CTS Auditoría y Finanzas Oct 25, 2024
Financial IT Compliance Senior Specialist London (The Westworks) Reino Unido Finance Corporate Auditoría y Finanzas Oct 25, 2024
Financial IT Compliance Manager London (The Westworks) Reino Unido Finance Corporate Auditoría y Finanzas Oct 25, 2024
BPA (Budget & Planning Analyst) İstanbul Kurtköy Turquía Finance Innovative Medicines Auditoría y Finanzas Oct 10, 2024
Associate Director, M&A Planning & Integration East Hanover Estados Unidos Finance Corporate Auditoría y Finanzas Oct 17, 2024
Senior Accounting Specialist Basel (City) Suiza Finance CTS Auditoría y Finanzas Oct 25, 2024
Treasury Cash Management Specialist INSURGENTES México Finance CTS Auditoría y Finanzas Oct 25, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japón Finance CTS Auditoría y Finanzas Jun 26, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japón Finance CTS Auditoría y Finanzas Oct 06, 2024
Treasury Manager Moscow (City) Federación Rusa Finance CTS Auditoría y Finanzas Jun 20, 2024
R2R Accountant Moscow (City) Federación Rusa Finance CTS Auditoría y Finanzas Oct 22, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Auditoría y Finanzas Jul 17, 2024
Ethics, Risk & Compliance Manager Selangor Malasia Ethics Risk & Compliance Innovative Medicines Propiedad legal e intelectual y cumplimiento Aug 22, 2024
Sr Manager/Manager-Monitoring Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Propiedad legal e intelectual y cumplimiento Jul 18, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malasia Ethics Risk & Compliance Corporate Propiedad legal e intelectual y cumplimiento Aug 29, 2024
Risk & Assurance Manager Mumbai (Head Office) India Ethics Risk & Compliance Innovative Medicines Propiedad legal e intelectual y cumplimiento Oct 16, 2024
Country ERC Head, India Mumbai (Office) India Ethics Risk & Compliance Innovative Medicines Propiedad legal e intelectual y cumplimiento Oct 16, 2024
Head DPDAI China Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Propiedad legal e intelectual y cumplimiento Oct 14, 2024
Manager- Data Privacy Review and Remediation Selangor Malasia Ethics Risk & Compliance Corporate Propiedad legal e intelectual y cumplimiento Oct 14, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) Francia Development Innovative Medicines Research & Development Sep 04, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Head, Clinical Development Business Solutions Basel (City) Suiza Development Innovative Medicines Research & Development Oct 10, 2024
Central Integrated Scientific Review Committee Lead Dublin (Novartis Corporate Center (NOCC)) Irlanda Development Innovative Medicines Research & Development Oct 14, 2024
Associate Director, Clinical Processes & Solutions Dublin (Novartis Corporate Center (NOCC)) Irlanda Development Innovative Medicines Research & Development Oct 14, 2024
Head Clinical Development Business Solutions East Hanover Estados Unidos Development Innovative Medicines Research & Development Oct 18, 2024
Country/ Cluster Head CRMA Ramallo (Argentina) Argentina Development Innovative Medicines Research & Development Aug 15, 2024
RA Manager INSURGENTES México Development Innovative Medicines Research & Development Sep 03, 2024
Clinical Research Medical Advisor Barcelona Gran Vía España Development Innovative Medicines Research & Development Sep 06, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Feasibility Manager INSURGENTES México Development Innovative Medicines Research & Development Oct 16, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Sep 05, 2024
Principal Clinical Data Manager Dublin (Novartis Corporate Center (NOCC)) Irlanda Development Innovative Medicines Research & Development Sep 26, 2024
Clinical Development Medical Director - Cardio-Renal-Metabolism East Hanover Estados Unidos Development Innovative Medicines Research & Development Sep 26, 2024
Senior Expert Data & Digital Hyderabad (Office) India Development Innovative Medicines Data and Digital Sep 27, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Sep 30, 2024
Clinical Development Medical Director Basel (City) Suiza Development Innovative Medicines Research & Development Sep 30, 2024
Administrative Expert / Professional RDQ Hyderabad (Office) India Development Innovative Medicines Instalaciones y Administración Aug 22, 2024
Director Biostatistics London (The Westworks) Reino Unido Development Innovative Medicines Research & Development Aug 22, 2024
Senior China Program Head Beijing (Beijing) China Development Innovative Medicines Research & Development Aug 22, 2024
Associate Clinical Development Medical Director Shanghai (Shanghai) China Development Innovative Medicines Research & Development Aug 22, 2024
RA CMC Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Patient Safety Specialist Amiria Egipto Development Innovative Medicines Research & Development Aug 26, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 42
  • › Next page

Novartis México

Conoce Novartis
  • Nuestro Compromiso con México
  • Sala de Prensa
  • Somos el Lugar para Crecer
Nuestro Compromiso
  • Impacto en México
  • Acceso
  • Sostenibilidad Ambiental
Talento
  • Oportunidades Laborales
  • Nuestra forma de Trabajo
  • Diversidad e Inclusión (D&I)
  • Programas de Atracción de Talento
Footer Bottom
© 2024 Novartis MX
  • Aviso de Privacidad
  • Condiciones de uso
  • Configuración de cookies
  • Mapa del sitio
  • Accesibilidad
Directorio de Novartis
Sitio dirigido a audiencia local.
COFEPRIS Permiso de Publicidad: 233300201B1273
Consulte a su médico